Addex Therapeutics Ltd (ADXN) Q1 2025 Earnings Call Highlights: Strategic Advances and ...

By Yahoo! Finance   |   3 weeks ago
Addex Therapeutics Ltd (ADXN) Q1 2025 Earnings Call Highlights: Strategic Advances and ...

Addex's agent shows potential for chronic painful cough in conditions like pulmonary sarcoidosis. Dipraglurant in post-stroke rehab would be paired with physiotherapy. The GABAB modulator program with Indivior aims for a better baclofen for substance use disorders.

Read More

Did you find this insightful?